Northern Trust’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-62,601
| Closed | -$326K | – | 4342 |
|
|
2016
Q4 | $326K | Buy |
62,601
+3,455
| +6% | +$16.2K | ﹤0.01% | 3633 |
|
|
2016
Q3 | $276K | Sell |
59,146
-165
| -0.3% | -$770 | ﹤0.01% | 3647 |
|
|
2016
Q2 | $234K | Buy |
59,311
+6,840
| +13% | +$25.6K | ﹤0.01% | 3686 |
|
|
2016
Q1 | $163K | Sell |
52,471
-158
| -0.3% | -$529 | ﹤0.01% | 3799 |
|
|
2015
Q4 | $240K | Buy |
52,629
+4,400
| +9% | +$20.9K | ﹤0.01% | 3706 |
|
|
2015
Q3 | $228K | Sell |
48,229
-158,758
| -77% | -$1.03M | ﹤0.01% | 3700 |
|
|
2015
Q2 | $1.48M | Sell |
206,987
-20,815
| -9% | -$157K | ﹤0.01% | 3198 |
|
|
2015
Q1 | $1.93M | Sell |
227,802
-12,855
| -5% | -$109K | ﹤0.01% | 3143 |
|
|
2014
Q4 | $2.24M | Sell |
240,657
-13,096
| -5% | -$114K | ﹤0.01% | 3028 |
|
|
2014
Q3 | $2.11M | Buy |
253,753
+3,441
| +1% | +$31.9K | ﹤0.01% | 3065 |
|
|
2014
Q2 | $2.89M | Sell |
250,312
-4,108
| -2% | -$42.2K | ﹤0.01% | 2867 |
|
|
2014
Q1 | $3.23M | Buy |
254,420
+43,938
| +21% | +$568K | ﹤0.01% | 2842 |
|
|
2013
Q4 | $2.28M | Buy |
210,482
+3,825
| +2% | +$44.4K | ﹤0.01% | 3075 |
|
|
2013
Q3 | $2.56M | Buy |
206,657
+34,511
| +20% | +$477K | ﹤0.01% | 2948 |
|
|
2013
Q2 | $2.3M | Buy |
+172,146
| New | +$2.21M | ﹤0.01% | 2902 |
|
Other funds holding DSCI
Northern Trust's DSCI Position: Q1 2017 in Review
Northern Trust sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 62,601 shares — an estimated $326K sold.
Northern Trust first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $3.23M in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.
- Northern Trust reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
- Northern Trust sold 62,601 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $326K.
- Northern Trust first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 15 quarters.
- Northern Trust's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.23M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.
Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.